Spectrum Pharma’s cancer drug meets main goal in trial

#bipolardisorder #zen

Health News Headlines – Yahoo News
Spectrum Pharma’s cancer drug meets main goal in trial
(Reuters) – Spectrum Pharmaceuticals Inc said its experimental blood cancer drug was shown to be safe and effective in a mid-stage trial, sending its shares up 10 percent. The injectable drug, Captisol-enabled melphalan, an improved form of common chemotherapy drug melphalan, is being tested in patients with multiple myeloma undergoing stem cell transplants. High-dose chemotherapy in combination with stem cell transplants is an option for patients with multiple myeloma, a form of blood cancer that originates in the bone marrow. The higher dose of chemotherapy given during the treatment destroys more myeloma cells.

Boise Bipolar Center, Charles K. Bunch, Ph.D, Boise Idaho Therapist Mental health photo 2168_zps680c452f.jpg

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s